Our results suggest that MAZ and p53 transcription factors co-operate in modulating miR-34a, as well as the expression of several miR-34a target genes in several pathways, including PI3K-AKT, with an impact on relapse and survival of breast cancer patients. Here, MAZ is linked to breast carcinoma.